Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

This study has been terminated.
(PI left VICC)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00082667
First received: May 14, 2004
Last updated: February 22, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2005
  Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)